192 related articles for article (PubMed ID: 20881042)
1. Peptide inhibitors of flavivirus entry derived from the E protein stem.
Schmidt AG; Yang PL; Harrison SC
J Virol; 2010 Dec; 84(24):12549-54. PubMed ID: 20881042
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibitors of dengue-virus entry.
Schmidt AG; Lee K; Yang PL; Harrison SC
PLoS Pathog; 2012; 8(4):e1002627. PubMed ID: 22496653
[TBL] [Abstract][Full Text] [Related]
3. Peptide inhibitors of dengue virus and West Nile virus infectivity.
Hrobowski YM; Garry RF; Michael SF
Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
[TBL] [Abstract][Full Text] [Related]
4. Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate.
Schmidt AG; Yang PL; Harrison SC
PLoS Pathog; 2010 Apr; 6(4):e1000851. PubMed ID: 20386713
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
[TBL] [Abstract][Full Text] [Related]
6. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
[TBL] [Abstract][Full Text] [Related]
7. Release of dengue virus genome induced by a peptide inhibitor.
Lok SM; Costin JM; Hrobowski YM; Hoffmann AR; Rowe DK; Kukkaro P; Holdaway H; Chipman P; Fontaine KA; Holbrook MR; Garry RF; Kostyuchenko V; Wimley WC; Isern S; Rossmann MG; Michael SF
PLoS One; 2012; 7(11):e50995. PubMed ID: 23226444
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate-related inhibitors of dengue virus entry.
Hidari KI; Abe T; Suzuki T
Viruses; 2013 Feb; 5(2):605-18. PubMed ID: 23389466
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.
Alhoot MA; Rathinam AK; Wang SM; Manikam R; Sekaran SD
Int J Med Sci; 2013; 10(6):719-29. PubMed ID: 23630436
[TBL] [Abstract][Full Text] [Related]
11. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI
Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel target sites and an inhibitor of the dengue virus E protein.
Yennamalli R; Subbarao N; Kampmann T; McGeary RP; Young PR; Kobe B
J Comput Aided Mol Des; 2009 Jun; 23(6):333-41. PubMed ID: 19241120
[TBL] [Abstract][Full Text] [Related]
13. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
14. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
[TBL] [Abstract][Full Text] [Related]
16. Roles of small GTPase Rac1 in the regulation of actin cytoskeleton during dengue virus infection.
Wang JL; Zhang JL; Chen W; Xu XF; Gao N; Fan DY; An J
PLoS Negl Trop Dis; 2010 Aug; 4(8):. PubMed ID: 20824170
[TBL] [Abstract][Full Text] [Related]
17. Molecular Aspects of the Dengue Virus Infection Process: A Review.
Zonetti LFC; Coutinho MC; de Araujo AS
Protein Pept Lett; 2018; 25(8):712-719. PubMed ID: 29984641
[TBL] [Abstract][Full Text] [Related]
18. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
Chin JF; Chu JJ; Ng ML
Microbes Infect; 2007 Jan; 9(1):1-6. PubMed ID: 17196419
[TBL] [Abstract][Full Text] [Related]
19. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.
Butrapet S; Childers T; Moss KJ; Erb SM; Luy BE; Calvert AE; Blair CD; Roehrig JT; Huang CY
Virology; 2011 Apr; 413(1):118-27. PubMed ID: 21353281
[TBL] [Abstract][Full Text] [Related]
20. Progress in the identification of dengue virus entry/fusion inhibitors.
De La Guardia C; Lleonart R
Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
